Industrial Parks Development Corporation (IPDC) said it will waive land lease payments for four years for pharmaceutical and medical device manufacturers that acquire land in the Kilinto Special Economic Zone, a move aimed at boosting local production and reducing reliance on imports.
Companies that secure land in the zone will also receive fully equipped plots with necessary infrastructure, the corporation said in a statement.
To qualify, manufacturers must produce pharmaceuticals or medical devices either for export or as import substitutes. Other requirements include self-financing the construction of manufacturing sheds, having at least one year of prior experience in the sector, creating jobs, and facilitating technology and knowledge transfer.
Ethiopia imports more than 90 percent of its medicines and medical supplies, spending hundreds of millions of dollars annually, according to industry data. The government has accelerated efforts to attract private investment into local drug production, with Kilinto positioned as a flagship hub.
The IPDC, which oversees Ethiopia’s network of industrial parks, has previously offered similar incentives to textile and agro-processing investors. Extending the benefits to pharmaceutical manufacturers marks a policy shift toward higher-value, technology-intensive sectors, officials said.
Officials hope the ready infrastructure and lease waiver will lower entry barriers for domestic and foreign investors, particularly those that bring skills and technology transfer a mandatory qualification under the program.
The move aligns with the African Continental Free Trade Area, under which Ethiopia seeks to become a regional exporter of generic drugs and medical devices.
However, challenges still remain, including foreign currency shortages, inconsistent power supply and bureaucratic hurdles. The IPDC has pledged to address those issues within the special economic zone framework.
